Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-25-000827)

Filing Details

Accession Number:: 0001140361-25-000827
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2025-01-10 16:01:48
Reporting Period:: 2025-01-02

Accepted Time:: 2025-01-10 16:01:48
Original Submission Date:: 2025-01-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124105	Gyre Therapeutics Inc.	GYRE	Pharmaceutical Preparations (2834)	562020050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1985547	Songjiang Ma	C/O Gyre Therapeutics, Inc. 12770 High Bluff Drive, Suite 150 San Diego CA 92130	President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-01-03	833	$11.85	2,918,467	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Spouse

Footnotes

This Form 4 amends the Form 4 filed on January 6, 2025 to reflect the correct transaction date as of January 3, 2025. The original filing incorrectly reported the transaction date as of January 3, 2024.